ArticleJournal of clinical practice and research2024
Neurological Complications in Children With Cancer: Experience From a Single Center in Türkiye.
Article in Journal of clinical practice and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to determine the neurological complications, etiological factors, and sequelae in children with cancer. Materials and Methods: This retrospective study examined the etiological factors, treatments, and outcomes of neurological complications in 794 children diagnosed with cancer at Erciyes University Faculty of Medicine. Results: The average age of the participants was 6.8 years (mean 6.8±4.8 years), including 448 (56.4%) boys, and 346 (43.6%) girls. A total of 506 neurological complications were identified in 313 children (39.4%). The most common neurological complications were walking difficulties, headaches, convulsions, and disorders affecting strength, vision, and hearing. The rate of neurological complications was 26.6% among patients with acute lymphoblastic leukemia, with no significant association found between risk groups and the occurrence of neurological complications. However, a significant relationship was observed between neurological complications and increased mortality. Conclusion: The rate of neurological complications was found to be higher in patients with non-Hodgkin lymphoma (NHL) compared to those with Hodgkin lymphoma (HL). Neurological complications emerge as a risk factor for mortality among children with systemic cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.